Biologics

Baxter International received FDA 510(k) clearance for its Altapore Bioactive Bone Graft for spinal fusion.

Minneapolis-based University of Minnesota Medical School researchers are using 3D technology to identify skeletal muscle stem cells for transplantation, according to Health Data Management.

Female ankylosing spondylitis patients do not respond as well to biologic treatment as their male counterparts, according to a study presented at the International Congress on Spondyloarthritides 2018 in Gent, Belgium, Oct. 4-8, and reported in Medscape.

Natesh Parashurama, MD, PhD, is a former surgeon and current stem cell researcher. Dr. Parashurama is an assistant chemical and biological engineering professor at the University of Buffalo (N.Y.), where he builds 3D internal organs from human stem cells.

Dallas-based University of Texas Southwestern Medical Center researchers are developing a stem cell-based treatment for a rare spinal cord disorder.

The Louis V. Gerstner Jr. Fund at Vanguard Charitable gave Rochester, Minn.-based Mayo Clinic a $10 million grant.

Heraeus Medical launched the Palacos R & R+G pro All-in-One Fixation System for the U.S. market.

Artoss is an orthobiologics company.

InVivo Therapeutics entered into a joint research agreement with Q Therapeutics to evaluate the safety and feasibility of combining InVivo's Neuro-Spinal Scaffold with stem cells.

Bioventus received approval to market Durolane for hip and knee osteoarthritis in Brazil and selected Pfizer as its exclusive distribution partner.